Your browser doesn't support javascript.
loading
Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders.
Abu-Raya, Bahaa; Madhi, Shabir A; Omer, Saad B; Amirthalingam, Gayatri; Giles, Michelle L; Flanagan, Katie L; Zimmermann, Petra; O'Ryan, Miguel; Safadi, Marco A; Papaevangelou, Vassiliki; Maertens, Kirsten; Wanlapakorn, Nasamon; Diaz-Brito, Vicens; Tommelein, Eline; Esposito, Susanna.
Affiliation
  • Abu-Raya B; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Madhi SA; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Omer SB; African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Amirthalingam G; Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, United States.
  • Giles ML; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States.
  • Flanagan KL; Immunisation and Countermeasures Division, National Infection Service, Public Health England, London, United Kingdom.
  • Zimmermann P; Department of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia.
  • O'Ryan M; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Safadi MA; School of Medicine, Faculty of Health Sciences, University of Tasmania, Launceston, TAS, Australia.
  • Papaevangelou V; School of Health and Biomedical Science, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, VIC, Australia.
  • Maertens K; Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.
  • Wanlapakorn N; Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS, Australia.
  • Diaz-Brito V; Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • Tommelein E; Department of Paediatrics, Fribourg Hospital HFR, Fribourg, Switzerland.
  • Esposito S; Microbiology and Mycology Program, Institute of Biomedical Sciences and Millennium Institute of Immunology and Immunotherapy, Faculty of Medicine, University of Chile, Santiago de Chile, Chile.
Front Immunol ; 12: 808064, 2021.
Article in En | MEDLINE | ID: mdl-35003137
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Maternal-Fetal Exchange / Antibodies, Viral Type of study: Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: Canada Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Maternal-Fetal Exchange / Antibodies, Viral Type of study: Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: Canada Country of publication: Switzerland